115 related articles for article (PubMed ID: 38886630)
1. Mediating role of chiro-inositol metabolites on the effects of HLA-DR-expressing CD14 + monocytes in inflammatory bowel disease.
Zhang L; Shen P; Ge W; Liao W; Luo Q; Li C; Zhan C; Yuan X; Zhang X; Yan X
BMC Gastroenterol; 2024 Jun; 24(1):200. PubMed ID: 38886630
[TBL] [Abstract][Full Text] [Related]
2. CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
Abeles RD; McPhail MJ; Sowter D; Antoniades CG; Vergis N; Vijay GK; Xystrakis E; Khamri W; Shawcross DL; Ma Y; Wendon JA; Vergani D
Cytometry A; 2012 Oct; 81(10):823-34. PubMed ID: 22837127
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR(hi) and CCR9 Define a Pro-Inflammatory Monocyte Subset in IBD.
Linton L; Karlsson M; Grundström J; Hjalmarsson E; Lindberg A; Lindh E; Glise H; Befrits R; Janczewska I; Karlén P; Winqvist O; Eberhardson M
Clin Transl Gastroenterol; 2012 Dec; 3(12):e29. PubMed ID: 23254312
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.
Vuk-Pavlović S; Bulur PA; Lin Y; Qin R; Szumlanski CL; Zhao X; Dietz AB
Prostate; 2010 Mar; 70(4):443-55. PubMed ID: 19902470
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.
Lin Y; Gustafson MP; Bulur PA; Gastineau DA; Witzig TE; Dietz AB
Blood; 2011 Jan; 117(3):872-81. PubMed ID: 21063024
[TBL] [Abstract][Full Text] [Related]
6. CD14(+) HLA-DR low/(-) monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma.
Khalifa KA; Badawy HM; Radwan WM; Shehata MA; Bassuoni MA
Int J Lab Hematol; 2014 Dec; 36(6):650-5. PubMed ID: 24636145
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive monocytes (CD14
Lima DS; Lemes RPG; Matos DM
Med Oncol; 2018 Feb; 35(3):36. PubMed ID: 29429058
[TBL] [Abstract][Full Text] [Related]
8. Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?
Tillinger W; Jilch R; Waldhoer T; Reinisch W; Junger W
Shock; 2013 Aug; 40(2):89-94. PubMed ID: 23860582
[TBL] [Abstract][Full Text] [Related]
9. Causal effects of inflammatory bowel disease on risk of type 2 diabetes: a two-sample multivariable Mendelian randomization study.
Niu Y; Zhang Q; Wei Y
Acta Diabetol; 2024 Jun; 61(6):715-724. PubMed ID: 38427067
[TBL] [Abstract][Full Text] [Related]
10. The causal effect of inflammatory bowel disease on diffuse large B-cell lymphoma: two-sample Mendelian randomization study.
Lu C; Chen Q; Tao H; Xu L; Li J; Wang C; Yu L
Front Immunol; 2023; 14():1171446. PubMed ID: 37593734
[TBL] [Abstract][Full Text] [Related]
11. Causal role of immune cells in inflammatory bowel disease: A Mendelian randomization study.
Chen H; Li Q; Gao T; Wang Y; Ren X; Liu S; Zhang S; Zhou P; Lyu J; Bai H; Wang Y
Medicine (Baltimore); 2024 Apr; 103(14):e37537. PubMed ID: 38579066
[TBL] [Abstract][Full Text] [Related]
12. The CD14
Mengos AE; Gastineau DA; Gustafson MP
Front Immunol; 2019; 10():1147. PubMed ID: 31191529
[TBL] [Abstract][Full Text] [Related]
13. Reduced Expression of HLA-DR on Monocytes During Severe Respiratory Syncytial Virus Infections.
Ahout IM; Jans J; Haroutiounian L; Simonetti ER; van der Gaast-de Jongh C; Diavatopoulos DA; de Jonge MI; de Groot R; Ferwerda G
Pediatr Infect Dis J; 2016 Mar; 35(3):e89-96. PubMed ID: 26658377
[TBL] [Abstract][Full Text] [Related]
14. The genetic relationships between immune cell traits, circulating inflammatory proteins and preeclampsia/eclampsia.
Liu Y; Zhang Y; Du L; Chen D
Front Immunol; 2024; 15():1389843. PubMed ID: 38873604
[TBL] [Abstract][Full Text] [Related]
15. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
[TBL] [Abstract][Full Text] [Related]
16. Causal linkage between type 2 diabetes mellitus and inflammatory bowel disease: an integrated Mendelian randomization study and bioinformatics analysis.
Xiao X; Wu X; Yi L; You F; Li X; Xiao C
Front Endocrinol (Lausanne); 2024; 15():1275699. PubMed ID: 38313367
[TBL] [Abstract][Full Text] [Related]
17. Causal relationship between eosinophilic esophagitis and inflammatory bowel disease: a bidirectional two-sample Mendelian randomization study.
Ji R; Zhi Y
Front Immunol; 2024; 15():1374107. PubMed ID: 38720886
[TBL] [Abstract][Full Text] [Related]
18. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
Höchst B; Schildberg FA; Sauerborn P; Gäbel YA; Gevensleben H; Goltz D; Heukamp LC; Türler A; Ballmaier M; Gieseke F; Müller I; Kalff J; Kurts C; Knolle PA; Diehl L
J Hepatol; 2013 Sep; 59(3):528-35. PubMed ID: 23665041
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease and allergic diseases: A Mendelian randomization study.
Li J; Wang L; Ma Y; Liu Y
Pediatr Allergy Immunol; 2024 May; 35(5):e14147. PubMed ID: 38773751
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
